Fungi-Mediated Synthesis of Nanoparticles: Comparison
View Latest Version
Please note this is a comparison between Version 2 by Camila Xu and Version 1 by Elena Vetchinkina.

Fungi are very promising biological objects for the green synthesis of nanoparticles. Biogenic synthesis of nanoparticles using different mycological cultures and substances obtained from them is a promising, easy and environmentally friendly method. By varying the synthesis conditions, the same culture can be used to produce nanoparticles with different sizes, shapes, stability in colloids and, therefore, different biological activity. Fungi are capable of producing a wide range of biologically active compounds and have a powerful enzymatic system that allows them to form nanoparticles of various chemical elements.

  • biogenic nanoparticles
  • green synthesis
  • metals and metalloids

1. Introduction

The most important task of modern nanotechnology is the development of reliable and efficient techniques allowing one to produce monodisperse nanoparticles with needed parameters. Nanoparticle production methods can be divided into physical, chemical and biological (or bio-assisted) [1[1][2],2], as well as combined methods putting together biological materials and physical influences, such as microwave radiation [3,4][3][4]. The chemical and physical methods traditionally used to produce nanoparticles allow large quantities of particles to be synthesized in a short time, but they are often expensive and difficult to perform; the issue of their environmental safety is a big problem as well. Therefore, in recent years, there has been an increasing interest in green nanotechnology and the biological synthesis of nanoparticles [5,6,7,8][5][6][7][8]. The introduction of green synthesis techniques can reduce the negative impact of nanotechnology on the environment by using less toxic reagents and reducing the risks of secondary pollution. Furthermore, nanoparticles produced via biosynthesis may have higher stability and biocompatibility and lower toxicity owing to their coating with biogenic surfactants or capping agents [9,10,11][9][10][11].
The ability to form nanoparticles has been found in all groups of organisms. Numerous studies have shown that plants [12[12][13][14][15],13,14,15], animals [10[10][16][17],16,17], bacteria [16,18][16][18], fungi [11[11][19][20][21],19,20,21], actinomycetes [22[22][23],23], algae [14,16,24[14][16][24][25],25], lichens [26] and viruses [10] can be successfully used to produce nanoparticles. Along with living cultures, their biomass, cell fractions, extracts, metabolites and spent media can also be used in green nanosynthesis [6[6][11][12][14][27][28],11,12,14,27,28], as well as various plant and animal food products [29,30,31,32][29][30][31][32] and organic industrial wastes [33,34,35][33][34][35]. Fungal cultures of different taxonomic groups are very promising biological objects for the green synthesis of nanoparticles [11,20,36][11][20][36]. The advantage of fungi in comparison to other organisms is their ability to produce a wide range of active protein molecules, convert ions of heavy metals and other trace elements into less toxic forms under the action of their enzymes and accumulate them in large quantities both within their mycelium and extracellularly. Therefore, fungi-mediated nanosynthesis has been increasingly studied in the past two decades. In fungal cultures, the ability to form a wide range of nanoparticles of different chemical compositions was found, including metals, metalloids, metal oxides and sulfides and other compounds, as well as composite nanoparticles [19,36,37][19][36][37].
All biological methods of nanosynthesis can be divided into two main types. In the first one, living cultures are used directly to serve as “nanofactories“, forming nanoparticles in vivo and accumulating them in their cells, on their cell surface or in the medium. Fungal biomass separated from the culture liquid can also be used. The disadvantage of this method is the need to separate the obtained nanoparticles from the bio-object’s cells; moreover, the process of biosynthesis by growing cultures may take a long time. The level of the precursor may also be a limiting factor, because high concentrations of metals and other compounds used to biosynthesize nanoparticles inhibit the growth processes. Another option for green nanoparticle synthesis is the use of various substances derived from bio-objects, such as culture liquids, intracellular extracts, protein fractions or individual fungal metabolites. The use of such techniques greatly facilitates the process of nanosynthesis, as there is no need to destroy the producing organism’s cells and separate nanoparticles from them.
The physico-chemical properties of nanoparticles are closely related not only to their chemical composition and crystal structure but also to their size and morphology, including particle physical shape, surface topography and the presence of pores and cavities [38,39][38][39]. It is also important that the synthesized nanoparticles are homogeneous in size and shape and resistant to aggregation in suspensions. The properties of biogenic nanoparticles have been found to depend on the species and strain of the microorganism, the extracts and metabolites used, the precursor compound and its concentration, media composition, stirring rate, incubation time, temperature, pH and other conditions, the varying of which can control nanoparticle formation [40,41,42][40][41][42]. The characteristics of the resulting nanoparticles determine their future applications. In this regard, an important challenge in nanobiotechnology is to develop methods allowing one to produce nanoparticles with better control over their size, shape and other properties. However, not enough attention has been paid to the study of the influence of the synthesis conditions on the properties of biogenic nanoparticles. In particular, there are still few comparative studies on the mycosynthesis of nanoparticles with different characteristics using the same fungal species but under different conditions.

2. Fungi-Mediated Synthesis of Nanoparticles

2.1. Mycosynthesis of Silver Nanoparticles

Owing to their unique features, silver nanoparticles (AgNPs) have many applications in various fields of medicine and engineering. The area of their applications includes electronic components, biomedical devices, textile engineering, cosmetics, agricultural engineering and many others [43,44][43][44]. AgNPs have been found to have a wide range of biological activities, including antibacterial, antifungal, antiviral, antitumor, hepatoprotective and hypotensive properties, which is why they are actively used for therapeutic purposes [45,46][45][46]. To date, the biological synthesis of AgNPs in fungi has been the most extensively studied of all elements. The ability to produce nanosilver has been detected in more than 120 species of fungi from different taxa, including Ascomycota (Alternaria [47], Aspergillus [48[48][49],49], Beauveria [50], Bionectria [51], Botryodiplodia [52], Chrysosporium [53], Cladosporium [54], Colletotrichum [55], Epicoccum [56], Fusarium [57,58][57][58], Geotricum [59], Guignardia [60], Helvella [61], Hormoconis [62], Humicola [63], Macrophomina [64], Neurospora [65], Paecilomyces [66], Penicillium [67,68,69[67][68][69][70][71][72],70,71,72], Pestalotia [73], Phoma [74[74][75],75], Picoa [76], Saccharomyces [77], Sclerotinia [78], Scopulariopsis [79], Talaromyces [80], Tirmania [81], Trichoderma [42[42][48][82][83][84],48,82,83,84], Verticillium [85], Yarrowia [86]), Mucoromycota (Rhizopus [87]) and Basidiomycota (Agaricus [41[41][88][89][90][91],88,89,90,91], Auricularia [92], Bjerkandera [93], Boletus [94], Calocybe [95], Coriolus [94], Cryptococcus [96], Flammulina [97[97][98],98], Fomes [99], Fomitopsis [100], Ganoderma [41[41][82][101][102],82,101,102], Grifola [41], Hypsizygus [103], Inonotus [104], Lactarius [105], Laxitextum [106], Lentinus [41[41][107],107], Microporus [108], Phaenerochaete [109], Phellinus [88], Piriformospora [110], Pleurotus [41,111,112[41][111][112][113][114],113,114], Pycnoporus [115], Rhodotorula [116], Schizophylluum [117], Trametes [118], Tricholoma [119], Volvariella [120]). Basidiomycetes are of particular interest as promising bio-objects for nanoparticle fabrication. Most of the basidiomycetes studied for mycosynthesis belong to edible and medicinal mushrooms, many of which are grown in artificial culture. These fungi produce a wide range of biologically active molecules, which not only can act as capping and stabilizing agents but also have anticancer, anti-inflammatory, antioxidant and antimicrobial activities themselves, allowing the production of nanoparticles with complex biomedical properties. The number of research papers on nanosilver mycosynthesis includes many dozens and is constantly growing. In recent years, there have been several reviews detailing the production of biogenic nanoparticles of this element using fungal cultures [45,121,122][45][121][122]. Therefore, below wresearchers will focus on some of the most recent publications in the past five years (Table 1).
Table 1.
Mycosynthesis of silver nanoparticles.
Species Source Precursor Nanoparticles References
Agaricus arvensis Living culture AgNO3 Spherical (10–20 nm) [41]
Cultural liquid AgNO3 Irregular spherical (10–100 nm)
Mycelial extract AgNO3 Spherical (1–10 nm)
Agaricus bisporus Living culture AgNO3 Spherical (10–20 nm) [41]
Cultural liquid AgNO3 Irregular spherical (10–100 nm)
Mycelial extract AgNO3 Spherical (1–10 nm)
Agaricus bisporus Crude polysaccharide extract AgNO3 Irregularly quasi-spherical (20–40 nm) [88]
Agaricus bisporus Fruit body extract AgNO3 Face-centered cubic (average size of 43.9 nm) [89]
Agaricus bisporus Fruit body extract AgNO3 Cubic (average size of 50.44 nm) [90]
Agaricus bisporus Fruit body extract AgNO3 Spherical (average size of 16 nm) [91]
Agaricus brasiliensis Crude polysaccharide extract AgNO3 Irregularly quasi-spherical (20–40 nm) [88]
Alternaria sp. Mycelial extract AgNO3 Spherical (3–10 nm) [47]
Aspergillus niger Crude xylanase AgNO3 Spherical, cylindrical, oval (15.21–77.49 nm) [48]
Auricularia polytricha Mycelial extract AgNO3 Spherical (5–50 nm) [92]
Beauveria bassiana Mycelial extract AgNO3 Triangular, circular, hexagonal (10–50 nm) [50]
Botryodiplodia theobromae
cultural liquid [139]. Spherical, pentagonal and hexagonal nanoparticles (5–30 nm) were obtained with Trichoderma hamatum mycelial extract [149]. The authors optimized the conditions for the synthesis of AuNPs with the smallest size using T. hamatum. Nanoparticles biosynthesized using T. harzianum mycelial biomass had a nanometric size distribution below 30 nanometers and a spherical shape [150]. AuNPs of variable shapes with considerable antibacterial, antioxidant and antimitotic activities were obtained with an Alternaria spp. extract [135]. Gold nanospheres (10–100 nm) with antibacterial and antifungal properties were obtained using Phoma sp. mycelial biomass [148]. Cubic AuNPs with strong antimicrobial, cytotoxic and antioxidant activity were synthesized using a Morchella esculenta fruit body extract [147]. Molnár et al. studied AuNP mycosynthesis by 29 thermophilic fungi and compared the results of three different approaches for the synthesis of gold nanoparticles using the extracellular fraction, the autolysate or the intracellular fraction of the fungi [152]. They observed the formation of nanoparticles with different sizes (ranging between 6 nm and 40 nm) and size distributions depending on the fungal strain and experimental conditions. Vetchinkina et al. studied AuNP mycosynthesis by A. bisporus and Agaricus arvensis cultures [41,153][41][153]. The use of live cultures, culture liquids and mycelial extracts resulted in the formation of nanoparticles of different sizes and shapes. Nanospheres were formed with living cultures and culture liquids, while irregularly spherical particles in the case of A. bisporus and various shapes with A. arvensis were formed using intracellular mycelial extracts. An extract from the A. bisporus fruit body was prepared and utilized as a reducing and stabilizing agent toward a green synthesis of AuNPs [134]. The different parameters such as the precursor concentration, precursor:extract ratio, pH, temperature, reaction mode and reaction time were optimized for the mycosynthesis of AuNPs. The synthesized gold nanospheres (10–50 nm) significantly inhibited the growth of clinically important pathogenic Gram-positive and Gram-negative bacteria and pathogenic fungi. AuNPs with a dye-degrading activity obtained by Dheyab et al. using an A. bisporus fruit body extract were oval, spherical, drum-like, hexagonal and triangular (average size of 53 nm) [133]. An A. bisporus mushroom extract was also used to synthesize gold nanospheres through a hydrothermal process (at a pressure of 15 psi and a temperature of 121°C for 15 min) [132]. The optimal conditions for the maximum nanoparticle concentration and stability were selected. Face-centered cubic nanocrystals with dye-reducing properties were synthesized using phenolic compounds isolated from Ganoderma applanatum [141]. Anticancer AuNPs biofabricated using a G. lucidum fruit body extract exhibited shapes such as spherical, oval and irregular, and their size ranged between 1 and 100 nm [142]. AuNPs synthesized using G. lucidum living cultures, as well as cultural liquid, were spherical, while the use of G. lucidum mycelial extract resulted in spherical, hexagonal, tetragonal and triangular particle formation [41]. The same results were obtained for Grifola frondosa and Pleurotus ostreatus cultures as well [41]. Chaturvedi et al. combined AuNP synthesis with the use of a P. sajor-caju fruit body extract followed by microwave irritation to further enhance the effects of fabricated gold nanospheres [113]. Vetchinkina et al. studied AuNP mycosynthesis by the L. edodes culture [41]. Living cultures formed nanospheres of 5–50 nm; smaller nanospheres were formed by the incubation of culture liquid with HAuCl4, and spherical, hexagonal, tetragonal and triangular particles of various sizes were formed with mycelial extract. Nanoparticles different in shape and size were synthesized using enzymes isolated and purified from the L. edodes mycelium. Spherical nanoparticles (2–20 nm) were obtained using intracellular Mn-peroxidase, and particles forming with the use of intracellular laccases and tyrosinases were bigger and irregularly spherical, triangular and tetrahedral in shape. When AuNPs were made with extracts from different morphogenetic stages of L. edodes and G. lucidum, their size, shape and degree of aggregation differed between the morphological structures involved [128]. The cytotoxicity of the AuNPs was negligible in a broad concentration range. Other researchers used an L. edodes fruit body extract to produce AuNPs of various shapes [145]. Basu et al. obtained variously shaped gold nanoparticles using a Tricholoma crassum mycelial extract [151]. They showed that particle size could be altered by changing synthesis parameters such as temperature and substrate and precursor concentrations. A mixture of triangular, spherical and irregular shapes with an average size of 74.32 nm was fabricated using a Flammulina velutipes fruit body extract [138]. A chaga (Inonotus obliquus) medicinal mushroom extract induced the formation of mostly spherical AuNPs with a size below 20 nm [143]. These AuNPs are promising dual-modal (chemo-photothermal) therapeutic candidates for anticancer applications. The production of AuNPs by a Coprinus comatus fruit body extract and the effect of UV irradiation at different times on nanoparticle size were investigated [137]. Gold nanospheres were also obtained using fruit body extracts of Cantharellus sp. (average particle size of 60.6 nm) [136] and Laetiporus versisporus (average particle size of 10 nm) [144].

2.3. Mycosynthesis of Platinum Nanoparticles

Platinum nanoparticles (PtNPs) are of great interest in various fields of engineering and biomedicine owing to their unique physico-chemical (catalytic, magnetic and optical) and biological (antimicrobial, antioxidant, anticancer) properties [154,155,156][154][155][156]. The mycosynthesis of PtNPs is much less studied, as compared to that of silver and gold. To date, the ability to form nanoparticles of this noble metal has been detected in several Ascomycota species (Table 3).
Table 3.
Mycosynthesis of platinum nanoparticles.
Species Source Precursor Nanoparticles References
Alternaria alternata Cultural liquid H2PtCl6 Irregular (50–315) [157]
Fusarium oxysporum Mycelial biomass H2PtCl6 Hexagonal, pentagonal, circular, square, rectangular (10–100 nm) [158]
Fusarium oxysporum Purified mycelial enzyme PtCl2 Rectangular, triangular (100–180 nm) [159]
Purified mycelial enzyme H2PtCl6 Spherical (100–140 nm)
Fusarium oxysporum Mycelial extract H2PtCl6 Irregular (30–40 nm) [160]
Purified mycelial enzyme H2PtCl6 Circular, triangular, pentagonal, hexagonal, often as nanoplates (40–60 nm)
Fusarium oxysporum Mycelial biomass H2PtCl6 Spherical (15–30 nm) [161]
Fusarium oxysporum Cultural liquid H2PtCl6 Face-centered cubic (average size of 25 nm) [162]
Neurospora crassa Mycelial biomass H2PtCl6 Quazi-spherical single PtNPs (4–35 nm) and spherical nanoaggregates (20–110 nm) [163]
Mycelial extract H2PtCl6 Spherical nanoaggregates (17–76 nm), containing individual single crystals 2–3 nm in diameter
Penicillium chrysogenum Cultural liquid H2PtCl6 Spherical (5–40 nm) [164]
Saccharomyces boulardii Cell free extract H2PtCl6 Spherical (80–150 nm) [165]
Mycelial extract
AgNO
3 66.75–111.23 nm [52]
Mycelial biomass AgNO3 62.77–103 nm
Flammulina velutipes Fungal extract AgNO3 Spherical (average size of 21.4 nm) [97]
Flammulina velutipes Fruit body extract AgNO3 Spherical (average size of 22 nm) [98]
Fomes fomentarius Fruit body extract AgNO3 Spherical (10–20 nm) [99]
Fomitopsis pinicola
. The extract containing intracellular components of fungal strains was obtained from a mechanically disrupted mycelium, while for the extract containing extracellular components of fungal strains, the biomass was extracted without disruption. The second method produced smaller particles. A number of researchers have studied the effect of various additional external physical influences on the fungi-mediated nanoparticle formation and developed combined methods of myconanosynthesis to improve AgNP characteristics. For example, UV radiation enhanced the characteristics of AgNPs obtained with an Agaricus bisporus pilei extract [89]. Microwave irritation enhanced the properties of AgNPs synthesized with the use of a Pleurotus sajor-caju fruit body extract [113]. AgNPs were synthesized from Pleurotus florida fruit body extracts using different electro-magnetic radiations, microwaves, visible light and UV rays [111]. Microwave irradiation led to the synthesis of monodisperse AgNPs of 10 nm size within 150 s of exposure, whereas visible light and UV radiation led to the synthesis of polydisperse AgNPs with inconsistent dimensions. Numerous studies have shown that mycosynthesized AgNPs have antibacterial, antifungal, anticancer, antioxidant, larvicidal and other properties, and the same nanoparticles can exhibit a wide range of biological activities. For example, silver nanospheres obtained by using Flammulina velutipes had bactericidal, fungicidal, anti-Alzheimer, anticancer, antioxidant and anti-diabetic activities, as well as good biocompatibility against human red blood cells [97]. Silver nanospheres produced using Aspergillus niger and Trichoderma longibrachiatum xylanases exhibited antibacterial, antifungal, antioxidant, anticoagulant, thrombolytic and dye-degrading activities [48]. All these properties offer great prospects for biomedical applications of mycogenic AgNPs.

2.2. Mycosynthesis of Gold Nanoparticles

Gold nanoparticles (AuNPs) have attracted attention owing to their unique optical, electronic, thermal, chemical and biological properties. They have been used in chemical and biological sensing, bio-imaging, nonlinear optics, catalysis, targeted drug delivery, gene delivery and as antimicrobial and antioxidant agents, as well as in cancer, Alzheimer’s, cardiovascular and infectious disease therapy [129,130,131][129][130][131]. In the past two decades, the biological synthesis of gold nanoparticles by fungi has been studied almost as extensively as that of silver. The ability to form AuNPs has been found in dozens of micro- and macromycete species. The table shows the AuNP mycosynthesis data published in the past five years (Table 2).
Table 2.
Mycosynthesis of gold nanoparticles.
Species Source Precursor Nanoparticles References
Agaricus arvensis Living culture HAuCl4 Spherical (5–50 nm) [41]
124
]
Cultural liquid HAuCl4 Spherical (2–10 nm)
Mycelial extract HAuCl4 Irregular spherical (25–20 nm)
Agaricus bisporus Fruit body extract HAuCl4 Spherical (average size of 25 nm) [132]
Agaricus bisporus Living culture HAuCl4 Spherical (5–50 nm) [41]
Cultural liquid HAuCl4 Spherical (2–10 nm)
Ganoderma lucidum
Mycelial extract HAuCl4 Spherical (10–50 nm), hexagonal, tetragonal, triangular (30–100 nm)
Agaricus bisporus Fruit body extract HAuCl4 Oval, spherical, drum-like, hexagonal, triangular (average size of 53 nm) [133]
Agaricus bisporus Fruit body extract HAuCl4 Spherical (10–50 nm) [134]
Alternaria spp. Fungal extract HAuCl4 Triangular, circular (average size of 28 nm) [135]
Cantharellus sp. Fungal extract HAuCl4 Spherical (average size of 60.6 nm) [136]
Coprinus comatus Fruit body extract HAuCl4 Face-centered cubic (average size of 17.39 nm) [137]
Flammulina velutipes Fruit body extract HAuCl4 Triangular, spherical, irregular (average size of 74.32 nm) [138]
Fusarium oxysporum Cultural liquid HAuCl4 Spherical, hexagonal (22–30 nm) [139]
Fruit body extract
AgNO
3
Spherical (average size of 11.38 nm)
[125]
Ganoderma sessile Mycelial extract AgNO3 Quasi-spherical (average size of 5.4 or 8.9 nm depending on the extraction method) [82]
Ganoderma sessiliforme Fruit body extract AgNO3 Spherical (average size of 45 nm) [101]
Fusarium solani Biomass extract HAuCl4 Needle and flower-like structures with spindle shape (40–45 nm) [140]
Ganoderma applanatum Isolated phenolic compounds HAuCl4 Face-centered cubic (average size of 18.70 nm) [141]
Ganoderma lucidum Living culture HAuCl4 Spherical (5–50 nm) [41]
Cultural liquid HAuCl4 Spherical (5–60 nm) Fruit body extract
Mycelial extract HAuCl4 Spherical (10–50 nm), hexagonal, tetragonal, triangular (30–100 nm)
Ganoderma lucidum Fruit body extract HAuCl4 Spherical, oval, irregular (1–100 nm) [142] AgNO3 Spherical (10–30 nm) [100
Grifola frondosa]
Living culture HAuCl4 Spherical (5–50 nm) [41] Ganoderma applanatum Fruit body extract AgNO3 Spherical (average size of 58.77 nm) [102]
Ganoderma lucidum Living culture AgNO3 Spherical (10–20 nm) [41]
Cultural liquid HAuCl4 Spherical (2–10 nm)
Mycelial extract HAuCl4 Spherical (10–50 nm), hexagonal, tetragonal, triangular (30–100 nm) Cultural liquid AgNO3 Irregular spherical (10–100 nm)
Inonotus obliquus Fruit body extract HAuCl4 Mostly spherical (below 20 nm) [143] Mycelial extract AgNO3 Spherical (1–10 nm)
Laetiporus versisporus Fruit body extract HAuCl4 Spherical (average size of 10 nm) [144] Fruit body extract AgNO3
Lentinus edodesNear-cubic (20–200 nm)
Fruit body extract HAuCl4 Triangular, hexagonal, spherical, irregular (average size of 72 nm) [145] Ganoderma lucidum Fungal extract AgNO3 Spherical (23–58 nm) [123
Lentinus edodes Living culture HAuCl4]
Spherical (5–50 nm) [41,146][41][146] Ganoderma lucidum Fruit body extract AgNO3 Spherical (15–22 nm) [
Cultural liquid HAuCl4 Spherical (2–20 nm)
Mycelial extract HAuCl4 Spherical (10–50 nm), hexagonal, tetragonal, triangular (30–200 nm)
Intracellular Mn-peroxidase HAuCl4 Spherical (2–20 nm)
Intracellular laccases and tyrosinases HAuCl4 Irregular spherical, triangular, tetrahedral (5–120 nm) Grifola frondosa Living culture AgNO3 Spherical (10–20 nm) [41]
Morchella esculenta Fruit body extract HAuCl4 Face-centered cubic (average size of 16.51 nm) [147] Cultural liquid AgNO3 Irregular spherical (10–100 nm)
Penicillium janthinellum Mycelial extract HAuCl4 Spherical (1–40 nm) [69] Mycelial extract AgNO3 Spherical (1–10 nm)
Phoma sp. Mycelial biomass HAuCl4 Spherical (10–100 nm) [148] Helvella leucopus Fruit body extract AgNO3 Spherical (80–100 nm), aggregated [61]
Pleurotus ostreatus Living culture HAuCl4 Spherical (5–50 nm) [41] Lactarius piperatus Fruit body extract AgNO3 Spherical (average size of 49 nm) [
Cultural liquid HAuCl4105]
Lentinus edodes Living culture AgNO3 Spherical (10–20 nm) [41]
Spherical (2–20 nm)
Mycelial extract HAuCl4 Spherical (10–50 nm), hexagonal, tetragonal, triangular (30–200 nm) Cultural liquid AgNO3 Irregular spherical (10–100 nm), spherical conglomerates 50–250)
Pleurotus sajor-caju Fruit body extract HAuCl4 Spherical (average size of 16–18 nm) [113] Mycelial extract AgNO3 Spherical (1–10 nm)
Trichoderma hamatum Mycelial extract HAuCl4 Spherical, pentagonal, hexagonal (5–30 nm) [149] Lentinus tuber-regium
Trichoderma harzianumFruit body extract Mycelial biomassAgNO3 Spherical (5–35 nm) [107]
HAuCl4 Spherical (below 30 nm) [150] Penicillium citrinum
Tricholoma crassumMycelial extract Mycelial extractAgNO3 HAuCl4Spherical (2–5 nm) Circular, rhomboid (5 nm or less), hexagonal, cubic, triangular (4.36–22.94 nm)[67]
[151] Penicillium cyclopium Mycelial biomass AgNO3 Mostly irregular (12–25 nm) [68]
Penicillium janthinellum Mycelial extract AgNO3 Spherical (1–30 nm) [69]
Penicillium oxalicum Mycelial extract AgNO3 Spherical (60–80 nm) [70]
Penicillium oxalicum Mycelial extract AgNO3 Spherical (average size of 52.26 nm) [71]
Penicillium polonicum Mycelial extract AgNO3 Mostly spherical (10–15 nm), hexagonal, polyhedral (above 30 nm) [72]
Phaenerochaete chrysosporium Mycelial extract AgNO3 Spherical, oval (34–90 nm) [109]
Phellinus linteus Crude polysaccharide extract AgNO3 Irregularly quasi-spherical (20–40 nm) [88]
Picoa sp. Fruit body extract AgNO3 Irregular (average size of 19.5 nm) [76]
Pleurotus djamor Fruit body extract AgNO3 Spherical (average size of 55.76 nm) [114]
Pleurotus eryngii Fruit body extract AgNO3 Spherical (average size of 18.45 nm) [112]
Pleurotus florida Fruit body extract AgNO3 Spherical (average size of 10 nm) [111]
Pleurotus ostreatus Living culture AgNO3 Spherical (10–20 nm) [41]
Cultural liquid AgNO3 Irregular spherical (10–100 nm)
Mycelial extract AgNO3 Spherical (1–10 nm)
Pleurotus ostreatus Fruit body extract AgNO3 Spherical, hexagonal (18–82 nm) [126]
Pleurotus ostreatus Fruit body extract AgNO3 Spherical (average size of 28.44 nm) [114]
Pleurotus sajor caju Fruit body extract AgNO3 Spherical (11–44 nm) [127]
Pleurotus sajor caju Fruit body extract AgNO3 Spherical (average size of 15–20 nm) [113]
Tirmania sp. Fruit body extract AgNO3 Irregular, spherical (average size of 72 nm) [81]
Trametes trogii Mycelial extract AgNO3 Mostly spherical (5–65 nm) [118]
Trichoderma atroviride Mycelial extract AgNO3 15–25 nm [84]
Trichoderma atroviride Cultural liquid AgNO3 Spherical (20–30 nm) [42]
Mycelial extract AgNO3 Spherical (15–35 nm)
Trichoderma harzianum Mycelial extract AgNO3 Spherical (10–25 nm) [83]
Trichoderma harzianum Mycelial extract AgNO3 Quasi-spherical (average size of 9.6 or 19.1 nm depending on the extraction method) [82]
Trichoderma longibrachiatum Crude xylanase AgNO3 Spherical, cylindrical, oval (15.21–77.49 nm) [48]
Trichoderma longibrachiatum Cultural liquid AgNO3 Spherical (5–15 nm) [42]
Mycelial extract AgNO3 Spherical (10–25 nm)
As can be seen from the table, AgNPs are commonly spherical in shape; irregular, oval, cubic, triangular, polygonal and other shapes are less common. Extracts from fruit bodies and mycelium are the most frequently used biological material for AgNP mycosynthesis, while culture liquids, biomass, living cultures and fungal metabolites of different purity (including enzymes, polysaccharides and phenolic compounds) are less commonly used. A number of researchers have screened fungal cultures to find the most promising ones for AgNP biofabrication. For example, Qu et al. studied 10 Trichoderma species and found that AgNPs obtained using different species differed in the degree of antimicrobial activity [42]. Other researchers found that among nine different fungi isolated from metal-rich sites, a strain of Penicillium janthinellum exhibited maximum metal tolerance capacity and AgNP-synthesizing ability [69]. The shape, size, homogeneity and stability of nanoparticles are influenced by the process conditions, the optimization of which can improve the quality of the obtained particles. For example, Mohanta et al. used various ratios of a Ganoderma sessiliforme mushroom extract to AgNO3 for AgNP synthesis [101]. At a 0.5:10 ratio, nanoparticles formed very slowly; at a 1.5:10 ratio, the reaction was very rapid but nanoparticles formed large aggregates. The 1:10 ratio was optimal and allowed the authors to obtain nanoparticles with an average size of 45 nm with antimicrobial and antioxidant activity. In another study, the utilization of a Ganoderma lucidum fruit body extract was scrutinized under different operational conditions including the AgNO3:extract ratio, reaction time and temperature to establish an effective myconanosynthesis method with a high yield rate and nanoparticle stabilization [125]. Vetchinkina et al. studied the effect of the Lentinus edodes culture age and stage of ontogenesis on the biogenic AgNP synthesis using culture liquids of different ages [41] and extracts obtained from the different morphological structures of L. edodes [128]. Parametric optimization, including the concentration of AgNO3, fungal biomass, ratio of cell filtrate to AgNO3, pH, reaction time and presence of light, was performed for the rapid synthesis of silver nanoparticles by Penicillium polonicum [72]. For Trichoderma harzianum and Ganoderma sessile, different methods of mycelial extraction for silver mycosynthesis were compared [82]
As with silver, the ability to biosynthesize gold nanoparticles has been studied mainly in two groups of fungi—ascomycetes and basidiomycetes. Mycogenic AuNPs most often have a spherical shape, but triangular, hexagonal, cubic, irregular and other shapes were also found. Needle- and flower-like nanostructures with a spindle shape were obtained using Fusarium solani biomass extract [140]. Spherical and hexagonal particles 22–30 nm in size were mycosynthesized with the use of Fusarium oxysporum
PtNP biosynthesis has been best studied in F. oxysporum. Riddin et al. showed that the mycelial biomass of F. oxysporum is capable of producing nanoparticles of various shapes (hexagons, pentagons, circles, squares, rectangles) and sizes (10–100 nm) and determined the optimal conditions (pH, temperature and concentration of the precursor compound H2PtCl6) for maximum nanoparticle yield [158]. Nanoparticles were formed both extracellularly and intracellularly as well as on the hyphae surface, but only the extracellular production of nanoparticles proved to be statistically significant. In further studies [161], a hydrogenase with Pt(IV)-reductase activity was isolated from this strain of F. oxysporum. It was shown that the bioreduction of platinum salt by hydrogenase takes place by a passive process and not an active one as previously understood. PtNPs formed by cell-free mycelial extract and purified hydrogenase differed in size and shape. The particles formed with the extract were irregular in shape, with an average nanoparticle size of 30–40 nm. Circular, triangular, pentagonal and hexagonal nanoparticles, often appearing as nanoplates, with a mean size range of 40–60 nm, were formed using the enzyme. It was found that the oxidation state of the platinum salt also plays an important role in nanoparticle formation [160]. When PtCl2 was used as a precursor, large (100–180 nm) nanoparticles of predominantly rectangular and triangular shape forming aggregates were biosynthesized with F. oxysporum hydrogenase. Bioreduction of H2PtCl6 produced spherical monodisperse nanoparticles varying in size with the mean nanoparticle size between 100 and 140 nm. Syed and Ahmad were able to produce spherical PtNPs with a diameter of 15–30 nm using F. oxysporum mycelial biomass [161]. The particles were formed extracellularly and were capped by natural proteins secreted by the fungus and therefore did not require the addition of stabilizing agents. Gupta and Chundawat obtained face-centered cubic nanoparticles with an average size of 25 nm with antimicrobial and photocatalytic activity using F. oxysporum filtrate [162]. The use of Penicillium chrysogenum culture filtrate made it possible to obtain highly dispersed non-aggregating platinum nanospheres (5–40 nm) [164]. Another ascomycete in which the ability to synthesize platinum nanoparticles has been found is Neurospora crassa [163]. Incubation of mycelial biomass with H2PtCl6 produced extracellular PtNPs (4–35 nm in diameter) and spherical nanoaggregates (20–110 nm in diameter). Using a mycelial extract from the same fungi, round single-crystal nanoagglomerates with diameters of 17 to 76 nm were obtained, containing individual single crystals of approximately 2–3 nm in diameter. Nanoplatinum was also obtained using the culture filtrate of the phytopathogenic fungus Alternaria alternata [157]. The particles were found to be irregular in shape presenting an overall quasi-spherical, rectangular, tetrahedral and hexagonal as well as polygonal morphology. Their size varied in the range of 50–315 nm with an average size of 135 nm. Borse et al. investigated the production of platinum nanospheres using cell-free extract of Saccharomyces boulardii yeast biomass and the effect of parameters such as the concentration of H2PtCl6, temperature, pH, reaction time and cell concentration [165]. A cell mass concentration of 500 mg/ mLin, the presence of 0.5 mM chloroplatinic acid at 35 °C, pH 7 and 200 rpm for 36 h showed maximum PtNP synthesis. Under these conditions, platinum nanospheres (80–150 nm) with anticancer activity were formed. It was also shown that nanoparticles were formed intracellularly when whole yeast cells were incubated with H2PtCl6.

References

  1. Dhand, C.; Dwivedi, N.; Loh, X.J.; Jie Ying, A.N.; Verma, N.K.; Beuerman, R.W.; Lakshminarayanan, R.; Ramakrishna, S. Methods and strategies for the synthesis of diverse nanoparticles and their applications: A comprehensive overview. RSC Adv. 2015, 5, 105003–105037.
  2. Krichevsky, G.E. Ecological «Green» biosynthesis of metal nanoparticles, reality and potential of their use in various fields of medicine. NBICS-Sci. Technol. 2018, 2, 85–106.
  3. Joseph, S.; Mathew, B. Microwave-assisted green synthesis of silver nanoparticles and the study on catalytic activity in the degradation of dyes. J. Mol. Liq. 2015, 204, 184–191.
  4. Shakibaie, M.; Torabi-Shamsabad, R.; Forootanfar, H.; Amiri-Moghadam, P.; Amirheidari, B.; Adeli-Sardou, M.; Ameri, A. Rapid microwave-assisted biosynthesis of platinum nanoparticles and evaluation of their antioxidant properties and cytotoxic effects against MCF-7 and A549 cell lines. 3 Biotech 2021, 11, 511.
  5. Kharissova, O.V.; Dias, H.V.R.; Kharisov, B.I.; Pérez, B.O.; Pérez, V.M.J. The greener synthesis of nanoparticles. Trends Biotechnol. 2013, 31, 240–248.
  6. Ovais, M.; Khalil, A.; Ayaz, M.; Ahmad, I.; Nethi, S.; Mukherjee, S. Biosynthesis of Metal Nanoparticles via Microbial Enzymes: A Mechanistic Approach. Int. J. Mol. Sci. 2018, 19, 4100.
  7. Ali, M.A.; Ahmed, T.; Wu, W.; Hossain, A.; Hafeez, R.; Islam Masum, M.M.; Wang, Y.; An, Q.; Sun, G.; Li, B. Advancements in Plant and Microbe-Based Synthesis of Metallic Nanoparticles and Their Antimicrobial Activity against Plant Pathogens. Nanomaterials 2020, 10, 1146.
  8. Saravanan, A.; Kumar, P.S.; Karishma, S.; Vo, D.-V.N.; Jeevanantham, S.; Yaashikaa, P.R.; George, C.S. A review on biosynthesis of metal nanoparticles and its environmental applications. Chemosphere 2021, 264, 128580.
  9. Schröfel, A.; Kratošová, G.; Šafařík, I.; Šafaříková, M.; Raška, I.; Shor, L.M. Applications of biosynthesized metallic nanoparticles—A review. Acta Biomater. 2014, 10, 4023–4042.
  10. Das, R.K.; Pachapur, V.L.; Lonappan, L.; Naghdi, M.; Pulicharla, R.; Maiti, S.; Cledon, M.; Dalila, L.M.A.; Sarma, S.J.; Brar, S.K. Biological synthesis of metallic nanoparticles: Plants, animals and microbial aspects. Nanotechnol. Environ. Eng. 2017, 2, 18.
  11. Castro-Longoria, E. Fungal Biosynthesis of Nanoparticles, a Cleaner Alternative. In Fungal Applications in Sustainable Environmental Biotechnology; Purchase, D., Ed.; Fungal Biology; Springer International Publishing: Cham, Switzerland, 2016; pp. 323–351.
  12. Majeed, A.; Ullah, W.; Anwar, A.W.; Shuaib, A.; Ilyas, U.; Khalid, P.; Mustafa, G.; Junaid, M.; Faheem, B.; Ali, S. Cost-effective biosynthesis of silver nanoparticles using different organs of plants and their antimicrobial applications: A review. Mater. Technol. 2018, 33, 313–320.
  13. Vijayaraghavan, K.; Ashokkumar, T. Plant-mediated biosynthesis of metallic nanoparticles: A review of literature, factors affecting synthesis, characterization techniques and applications. J. Environ. Chem. Eng. 2017, 5, 4866–4883.
  14. Bao, Z.; Lan, C.Q. Advances in biosynthesis of noble metal nanoparticles mediated by photosynthetic organisms—A review. Colloids Surf. B Biointerfaces 2019, 184, 110519.
  15. Sorbiun, M.; Shayegan Mehr, E.; Ramazani, A.; Mashhadi Malekzadeh, A. Biosynthesis of metallic nanoparticles using plant extracts and evaluation of their antibacterial properties. Nanochemistry Res. 2018, 3, 1–16.
  16. Singh, C.R.; Kathiresan, K.; Anandhan, S. A review on marine based nanoparticles and their potential applications. Afr. J. Biotechnol. 2015, 14, 1525–1532.
  17. Jaganathan, A.; Murugan, K.; Panneerselvam, C.; Madhiyazhagan, P.; Dinesh, D.; Vadivalagan, C.; Aziz, A.T.; Chandramohan, B.; Suresh, U.; Rajaganesh, R.; et al. Earthworm-mediated synthesis of silver nanoparticles: A potent tool against hepatocellular carcinoma, Plasmodium falciparum parasites and malaria mosquitoes. Parasitol. Int. 2016, 65, 276–284.
  18. Koul, B.; Poonia, A.K.; Yadav, D.; Jin, J.-O. Microbe-Mediated Biosynthesis of Nanoparticles: Applications and Future Prospects. Biomolecules 2021, 11, 886.
  19. Owaid, M.N.; Ibraheem, I.J. Mycosynthesis of nanoparticles using edible and medicinal mushrooms. Eur. J. Nanomed. 2017, 9, 5–23.
  20. Adebayo, E.A.; Azeez, M.A.; Alao, M.B.; Oke, A.M.; Aina, D.A. Fungi as veritable tool in current advances in nanobiotechnology. Heliyon 2021, 7, e08480.
  21. Li, Q.; Liu, F.; Li, M.; Chen, C.; Gadd, G.M. Nanoparticle and nanomineral production by fungi. Fungal Biol. Rev. 2022, 41, 31–44.
  22. Manimaran, M.; Kannabiran, K. Actinomycetes-mediated biogenic synthesis of metal and metal oxide nanoparticles: Progress and challenges. Lett. Appl. Microbiol. 2017, 64, 401–408.
  23. Kumari, S.; Tehri, N.; Gahlaut, A.; Hooda, V. Actinomycetes mediated synthesis, characterization, and applications of metallic nanoparticles. Inorg. Nano-Met. Chem. 2020, 51, 1386–1395.
  24. Chaudhary, R.; Nawaz, K.; Khan, A.K.; Hano, C.; Abbasi, B.H.; Anjum, S. An Overview of the Algae-Mediated Biosynthesis of Nanoparticles and Their Biomedical Applications. Biomolecules 2020, 10, 1498.
  25. Li, S.-N.; Wang, R.; Ho, S.-H. Algae-mediated biosystems for metallic nanoparticle production: From synthetic mechanisms to aquatic environmental applications. J. Hazard. Mater. 2021, 420, 126625.
  26. Hamida, R.S.; Ali, M.A.; Abdelmeguid, N.E.; Al-Zaban, M.I.; Baz, L.; Bin-Meferij, M.M. Lichens—A Potential Source for Nanoparticles Fabrication: A Review on Nanoparticles Biosynthesis and Their Prospective Applications. J. Fungi 2021, 7, 291.
  27. Zhang, Y.; Zheng, G. Wang Biosynthesis of gold nanoparticles using chloroplasts. Int. J. Nanomed. 2011, 6, 2899.
  28. Durán, M.; Silveira, C.P.; Durán, N. Catalytic role of traditional enzymes for biosynthesis of biogenic metallic nanoparticles: A mini-review. IET Nanobiotechnol. 2015, 9, 314–323.
  29. Khanna, P.K.; Nair, C.K.K. Synthesis of Silver Nanoparticles Using Cod Liver Oil (Fish Oil): Green Approach to Nanotechnology. Int. J. Green Nanotechnol. Phys. Chem. 2009, 1, P3–P9.
  30. Lee, K.-J.; Park, S.-H.; Govarthanan, M.; Hwang, P.-H.; Seo, Y.-S.; Cho, M.; Lee, W.-H.; Lee, J.-Y.; Kamala-Kannan, S.; Oh, B.-T. Synthesis of silver nanoparticles using cow milk and their antifungal activity against phytopathogens. Mater. Lett. 2013, 105, 128–131.
  31. Huang, L.; Weng, X.; Chen, Z.; Megharaj, M.; Naidu, R. Green synthesis of iron nanoparticles by various tea extracts: Comparative study of the reactivity. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2014, 130, 295–301.
  32. González Fá, A.J.; Juan, A.; Di Nezio, M.S. Synthesis and Characterization of Silver Nanoparticles Prepared with Honey: The Role of Carbohydrates. Anal. Lett. 2017, 50, 877–888.
  33. Krishnaswamy, K.; Valib, H.; Orsata, V. Value-adding to grape waste: Green synthesis of gold nanoparticles. J. Food Eng. 2014, 142, 210–220.
  34. Ibrahim, H.M.M. Green synthesis and characterization of silver nanoparticles using banana peel extract and their antimicrobial activity against representative microorganisms. J. Radiat. Res. Appl. Sci. 2015, 8, 265–275.
  35. Bagherzade, G.; Tavakoli, M.M.; Namaei, M.H. Green synthesis of silver nanoparticles using aqueous extract of saffron (Crocus sativus L.) wastages and its antibacterial activity against six bacteria. Asian Pac. J. Trop. Biomed. 2017, 7, 227–233.
  36. Boroumand Moghaddam, A.; Namvar, F.; Moniri, M.; Tahir, P.M.; Azizi, S.; Mohamad, R. Nanoparticles Biosynthesized by Fungi and Yeast: A Review of Their Preparation, Properties, and Medical Applications. Molecules 2015, 20, 16540–16565.
  37. Bhanja, S.K.; Samanta, S.K.; Mondal, B.; Jana, S.; Ray, J.; Pandey, A.; Tripathy, T. Green synthesis of bimetallic composite nanoparticles using a polysaccharide extracted from Ramaria botrytis mushroom and performance in catalytic reduction of 4-nitrophenol and antioxidant, antibacterial activity. Environ. Nanotechnol. Monit. Manag. 2020, 14, 100341.
  38. Albanese, A.; Tang, P.S.; Chan, W.C.W. The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems. Annu. Rev. Biomed. Eng. 2012, 14, 1–16.
  39. Guisbiers, G.; Mejía-Rosales, S.; Deepak, F.L. Nanomaterial Properties: Size and Shape Dependencies. J. Nanomater. 2012, 2012, 180976.
  40. Khandel, P.; Shahi, S.K. Mycogenic nanoparticles and their bio-prospective applications: Current status and future challenges. J. Nanostruct. Chem. 2018, 8, 369–391.
  41. Vetchinkina, E.; Loshchinina, E.; Kupryashina, M.; Burov, A.; Nikitina, V. Shape and Size Diversity of Gold, Silver, Selenium, and Silica Nanoparticles Prepared by Green Synthesis Using Fungi and Bacteria. Ind. Eng. Chem. Res. 2019, 58, 17207–17218.
  42. Qu, M.; Yao, W.; Cui, X.; Xia, R.; Qin, L.; Liu, X. Biosynthesis of silver nanoparticles (AgNPs) employing Trichoderma strains to control empty-gut disease of oak silkworm (Antheraea pernyi). Mater. Today Commun. 2021, 28, 102619.
  43. Rafique, M.; Sadaf, I.; Rafique, M.S.; Tahir, M.B. A review on green synthesis of silver nanoparticles and their applications. Artif. Cells Nanomed. Biotechnol. 2017, 45, 1272–1291.
  44. Razak, N.H.A.; Zawawi, N.A.; Chundawat, T.S. Brief Review on Bioresources Green Synthesis of Silver Nanoparticles. J. Adv. Res. Mater. Sci. 2021, 76, 1–10.
  45. Khan, A.U.; Malik, N.; Khan, M.; Cho, M.H.; Khan, M.M. Fungi-assisted silver nanoparticle synthesis and their applications. Bioprocess Biosyst. Eng. 2018, 41, 1–20.
  46. Ratan, Z.A.; Haidere, M.F.; Nurunnabi, M.; Shahriar, S.M.; Ahammad, A.J.S.; Shim, Y.Y.; Reaney, M.J.T.; Cho, J.Y. Green Chemistry Synthesis of Silver Nanoparticles and Their Potential Anticancer Effects. Cancers 2020, 12, 855.
  47. Win, T.T.; Khan, S.; Fu, P. Fungus-(Alternaria sp.) Mediated Silver Nanoparticles Synthesis, Characterization, and Screening of Antifungal Activity against Some Phytopathogens. J. Nanotechnol. 2020, 2020, 8828878.
  48. Elegbede, J.A.; Lateef, A.; Azeez, M.A.; Asafa, T.B.; Yekeen, T.A.; Oladipo, I.C.; Adebayo, E.A.; Beukes, L.S.; Gueguim-Kana, E.B. Fungal xylanases-mediated synthesis of silver nanoparticles for catalytic and biomedical applications. IET Nanobiotechnol. 2018, 12, 857–863.
  49. Nanda, A.; Nayak, B.K.; Krishnamoorthy, M. Antimicrobial properties of biogenic silver nanoparticles synthesized from phylloplane fungus, Aspergillus tamarii. Biocatal. Agric. Biotechnol. 2018, 16, 225–228.
  50. Tyagi, S.; Tyagi, P.K.; Gola, D.; Chauhan, N.; Bharti, R.K. Extracellular synthesis of silver nanoparticles using entomopathogenic fungus: Characterization and antibacterial potential. SN Appl. Sci. 2019, 1, 1545.
  51. Rodrigues, A.G.; Ping, L.Y.; Marcato, P.D.; Alves, O.L.; Silva, M.C.P.; Ruiz, R.C.; Melo, I.S.; Tasic, L.; De Souza, A.O. Biogenic antimicrobial silver nanoparticles produced by fungi. Appl. Microbiol. Biotechnol. 2013, 97, 775–782.
  52. Janakiraman, V.; Govindarajan, K.; CR, M. Biosynthesis of Silver Nanoparticles from Endophytic Fungi, and its Cytotoxic Activity. BioNanoScience 2019, 9, 573–579.
  53. Soni, N.; Prakash, S. Possible Mosquito Control by Silver Nanoparticles Synthesized by Soil Fungus (Aspergillus niger 2587). Adv. Nanoparticles 2013, 02, 125–132.
  54. Manjunath Hulikere, M.; Joshi, C.G. Characterization, antioxidant and antimicrobial activity of silver nanoparticles synthesized using marine endophytic fungus- Cladosporium cladosporioides. Process Biochem. 2019, 82, 199–204.
  55. Azmath, P.; Baker, S.; Rakshith, D.; Satish, S. Mycosynthesis of silver nanoparticles bearing antibacterial activity. Saudi Pharm. J. 2016, 24, 140–146.
  56. Qian, Y.; Yu, H.; He, D.; Yang, H.; Wang, W.; Wan, X.; Wang, L. Biosynthesis of silver nanoparticles by the endophytic fungus Epicoccum nigrum and their activity against pathogenic fungi. Bioprocess Biosyst. Eng. 2013, 36, 1613–1619.
  57. Ingle, A.; Rai, M.; Gade, A.; Bawaskar, M. Fusarium solani: A novel biological agent for the extracellular synthesis of silver nanoparticles. J Nanopart Res 2009, 11, 2079–2085.
  58. Ishida, K.; Cipriano, T.F.; Rocha, G.M.; Weissmüller, G.; Gomes, F.; Miranda, K.; Rozental, S. Silver nanoparticle production by the fungus Fusarium oxysporum: Nanoparticle characterisation and analysis of antifungal activity against pathogenic yeasts. Mem. Inst. Oswaldo Cruz 2013, 109, 220–228.
  59. Jebali, A.; Ramezani, F.; Kazemi, B. Biosynthesis of Silver Nanoparticles by Geotricum sp. J. Clust. Sci. 2011, 22, 225–232.
  60. Balakumaran, M.D.; Ramachandran, R.; Kalaichelvan, P.T. Exploitation of endophytic fungus, Guignardia mangiferae for extracellular synthesis of silver nanoparticles and their in vitro biological activities. Microbiol. Res. 2015, 178, 9–17.
  61. Talie, M.D.; Hamid Wani, A.; Ahmad, N.; Yaqub Bhat, M.; Mohd War, J. Green synthesis of silver nanoparticles (AgNPs) using Helvella leucopus Pers. and their antimycotic activity against fungi causing fungal rot of apple. Asian J. Pharm. Clin. Res. 2020, 13, 161–165.
  62. Varshney, R.; Mishra, A.N.; Bhadauria, S.; Gaur, M.S. A novel microbial route to synthesize silver nanoparticles using fungus Hormoconis resinae. J. Nanomater. Biostruct. 2009, 4, 349–355.
  63. Syed, A.; Saraswati, S.; Kundu, G.C.; Ahmad, A. Biological synthesis of silver nanoparticles using the fungus Humicola sp. and evaluation of their cytoxicity using normal and cancer cell lines. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2013, 114, 144–147.
  64. Chowdhury, S.; Basu, A.; Kundu, S. Green synthesis of protein capped silver nanoparticles from phytopathogenic fungus Macrophomina phaseolina (Tassi) Goid with antimicrobial properties against multidrug-resistant bacteria. Nanoscale Res. Lett. 2014, 9, 365.
  65. Quester, K.; Avalos-Borja, M.; Castro-Longoria, E. Controllable Biosynthesis of Small Silver Nanoparticles Using Fungal Extract. J. Biomater. Nanobiotechnology 2016, 07, 118–125.
  66. Devi, L.; Joshi, S. Ultrastructures of silver nanoparticles biosynthesized using endophytic fungi. J. Microsc. Ultrastruct. 2015, 3, 29.
  67. Danagoudar, A.; Pratap, G.K.; Shantaram, M.; Ghosh, K.; Kanade, S.R.; Joshi, C.G. Characterization, cytotoxic and antioxidant potential of silver nanoparticles biosynthesised using endophytic fungus (Penicillium citrinum CGJ-C1). Mater. Today Commun. 2020, 25, 101385.
  68. Wanarska, E.; Maliszewska, I. The possible mechanism of the formation of silver nanoparticles by Penicillium cyclopium. Bioorganic Chem. 2019, 93, 102803.
  69. Pareek, V.; Bhargava, A.; Panwar, J. Biomimetic approach for multifarious synthesis of nanoparticles using metal tolerant fungi: A mechanistic perspective. Mater. Sci. Eng. B 2020, 262, 114771.
  70. Feroze, N.; Arshad, B.; Younas, M.; Afridi, M.I.; Saqib, S.; Ayaz, A. Fungal mediated synthesis of silver nanoparticles and evaluation of antibacterial activity. Microsc. Res. Tech. 2020, 83, 72–80.
  71. Seetharaman, P.K.; Chandrasekaran, R.; Periakaruppan, R.; Gnanasekar, S.; Sivaperumal, S.; Abd-Elsalam, K.A.; Valis, M.; Kuca, K. Functional Attributes of Myco-Synthesized Silver Nanoparticles from Endophytic Fungi: A New Implication in Biomedical Applications. Biology 2021, 10, 473.
  72. Neethu, S.; Midhun, S.J.; Sunil, M.A.; Soumya, S.; Radhakrishnan, E.K.; Jyothis, M. Efficient visible light induced synthesis of silver nanoparticles by Penicillium polonicum ARA 10 isolated from Chetomorpha antennina and its antibacterial efficacy against Salmonella enterica serovar Typhimurium. J. Photochem. Photobiol. B Biol. 2018, 180, 175–185.
  73. Raheman, F.; Deshmukh, S.; Ingle, A.; Gade, A.; Rai, M. Silver Nanoparticles: Novel Antimicrobial Agent Synthesized from an Endophytic Fungus Pestalotia sp. Isolated from Leaves of Syzygium cumini (L). Nano Biomed. Eng. 2011, 3, 174–178.
  74. Gade, A.K.; Bonde, P.; Ingle, A.P.; Marcato, P.D.; Durán, N.; Rai, M.K. Exploitation of Aspergillus niger for Synthesis of Silver Nanoparticles. J. Biobased Mater. Bioenergy 2008, 2, 243–247.
  75. Rai, M.; Ingle, A.P.; Gade, A.; Duran, N. Synthesis of silver nanoparticles by Phoma gardeniae and in vitro evaluation of their efficacy against human disease-causing bacteria and fungi. IET Nanobiotechnol. 2015, 9, 71–75.
  76. Owaid, M.N.; Rabeea, M.A.; Abdul Aziz, A.; Jameel, M.S.; Dheyab, M.A. Mycogenic fabrication of silver nanoparticles using Picoa, Pezizales, characterization and their antifungal activity. Environ. Nanotechnol. Monit. Manag. 2022, 17, 100612.
  77. Korbekandi, H.; Mohseni, S.; Mardani Jouneghani, R.; Pourhossein, M.; Iravani, S. Biosynthesis of silver nanoparticles using Saccharomyces cerevisiae. Artif. Cells Nanomed. Biotechnol. 2016, 44, 235–239.
  78. Saxena, J.; Sharma, P.K.; Sharma, M.M.; Singh, A. Process optimization for green synthesis of silver nanoparticles by Sclerotinia sclerotiorum MTCC 8785 and evaluation of its antibacterial properties. SpringerPlus 2016, 5, 861.
  79. Moustafa, M.T. Removal of pathogenic bacteria from wastewater using silver nanoparticles synthesized by two fungal species. Water Sci. 2017, 31, 164–176.
  80. Hu, X.; Saravanakumar, K.; Jin, T.; Wang, M.-H. Mycosynthesis, characterization, anticancer and antibacterial activity of silver nanoparticles from endophytic fungus Talaromyces purpureogenus. Int. J. Nanomed. 2019, 14, 3427–3438.
  81. Owaid, M. Biosynthesis of Silver Nanoparticles from Truffles and Mushrooms and Their Applications as Nanodrugs. Curr. Appl. Sci. Technol. 2021, 22, 1–11.
  82. Murillo-Rábago, E.I.; Vilchis-Nestor, A.R.; Juarez-Moreno, K.; Garcia-Marin, L.E.; Quester, K.; Castro-Longoria, E. Optimized Synthesis of Small and Stable Silver Nanoparticles Using Intracellular and Extracellular Components of Fungi: An Alternative for Bacterial Inhibition. Antibiotics 2022, 11, 800.
  83. Raja, M.; Sharma, R.K.; Jambhulkar, P.; Sharma, K.R.; Sharma, P. Biosynthesis of silver nanoparticles from Trichoderma harzianum Th3 and its efficacy against root rot complex pathogen in groundnut. Mater. Today Proc. 2021, 43, 3140–3143.
  84. Saravanakumar, K.; Wang, M.-H. Trichoderma based synthesis of anti-pathogenic silver nanoparticles and their characterization, antioxidant and cytotoxicity properties. Microb. Pathog. 2018, 114, 269–273.
  85. Mukherjee, P.; Ahmad, A.; Mandal, D.; Senapati, S.; Sainkar, S.R.; Khan, M.I.; Parishcha, R.; Ajaykumar, P.V.; Alam, M.; Kumar, R.; et al. Fungus-Mediated Synthesis of Silver Nanoparticles and Their Immobilization in the Mycelial Matrix: A Novel Biological Approach to Nanoparticle Synthesis. Nano Lett. 2001, 1, 515–519.
  86. Apte, M.; Sambre, D.; Gaikawad, S.; Joshi, S.; Bankar, A.; Kumar, A.R.; Zinjarde, S. Psychrotrophic yeast Yarrowia lipolytica NCYC 789 mediates the synthesis of antimicrobial silver nanoparticles via cell-associated melanin. AMB Express 2013, 3, 32.
  87. Ottoni, C.A.; Simões, M.F.; Fernandes, S.; dos Santos, J.G.; da Silva, E.S.; de Souza, R.F.B.; Maiorano, A.E. Screening of filamentous fungi for antimicrobial silver nanoparticles synthesis. AMB Express 2017, 7, 31.
  88. Klaus, A.; Petrovic, P.; Vunduk, J.; Pavlovic, V.; Van Griensven, L.J.L.D. The Antimicrobial Activities of Silver Nanoparticles Synthesized from Medicinal Mushrooms. Int. J. Med. Mushrooms 2020, 22, 869–883.
  89. Owaid, M.N.; Naeem, G.A.; Muslim, R.F.; Oleiwi, R.S. Synthesis, characterization and antitumor efficacy of silver nanoparticle from Agaricus bisporus pileus, Basidiomycota. Walailak J. Sci. Technol. 2020, 17, 75–87.
  90. Jameel, M.S.; Aziz, A.A.; Dheyab, M.A.; Khaniabadi, P.M.; Kareem, A.A.; Alrosan, M.; Ali, A.T.; Rabeea, M.A.; Mehrdel, B. Mycosynthesis of ultrasonically-assisted uniform cubic silver nanoparticles by isolated phenols from Agaricus bisporus and its antibacterial activity. Surf. Interfaces 2022, 29, 101774.
  91. Krishnamoorthi, R.; Mahalingam, P.U.; Malaikozhundan, B. Edible mushroom extract engineered Ag NPs as safe antimicrobial and antioxidant agents with no significant cytotoxicity on human dermal fibroblast cells. Inorg. Chem. Commun. 2022, 139, 109362.
  92. Abikoye, E.T.; Oloke, J.K.; Elemo, G.; Okorie, P.C.; Aier, S.; Oluwawole, O.F.; Barooah, M. Biosynthesis of silver nanoparticles in improved strain of Auricularia polytricha—An edible mushroom from Nigeria and its antimicrobial activities. Covenant J. Phys. Life Sci. (Spec. Ed.) 2019, 7, 47–55.
  93. Osorio-Echavarría, J.; Osorio-Echavarría, J.; Ossa-Orozco, C.P.; Gómez-Vanegas, N.A. Synthesis of silver nanoparticles using white-rot fungus Anamorphous Bjerkandera sp. R1: Influence of silver nitrate concentration and fungus growth time. Sci. Rep. 2021, 11, 3842.
  94. Kaplan, Ö.; Gökşen Tosun, N.; Özgür, A.; Erden Tayhan, S.; Bilgin, S.; Türkekul, İ.; Gökce, İ. Microwave-assisted green synthesis of silver nanoparticles using crude extracts of Boletus edulis and Coriolus versicolor: Characterization, anticancer, antimicrobial and wound healing activities. J. Drug Deliv. Sci. Technol. 2021, 64, 102641.
  95. Mirunalini, S.; Arulmozhi, V.; Deepalakshmi, K.; Krishnaveni, M. Intracellular Biosynthesis and Antibacterial Activity of Silver Nanoparticles Using Edible Mushrooms. Not. Sci. Biol. 2012, 4, 55–61.
  96. Fernández, J.G.; Fernández-Baldo, M.A.; Berni, E.; Camí, G.; Durán, N.; Raba, J.; Sanz, M.I. Production of silver nanoparticles using yeasts and evaluation of their antifungal activity against phytopathogenic fungi. Process Biochem. 2016, 51, 1306–1313.
  97. Faisal, S.; Khan, M.A.; Jan, H.; Shah, S.A.; Abdullah; Shah, S.; Rizwan, M.; Wajidullah; Akbar, M.T. Redaina Edible mushroom (Flammulina velutipes) as biosource for silver nanoparticles: From synthesis to diverse biomedical and environmental applications. Nanotechnology 2021, 32, 065101.
  98. Zhang, L.; Wei, Y.; Wang, H.; Wu, F.; Zhao, Y.; Liu, X.; Wu, H.; Wang, L.; Su, H. Green synthesis of silver nanoparticles using mushroom Flammulina velutipes extract and their antibacterial activity against aquatic pathogens. Food Bioprocess Technol. 2020, 13, 1908–1917.
  99. Rehman, S.; Farooq, R.; Jermy, R.; Mousa Asiri, S.; Ravinayagam, V.; Al Jindan, R.; Alsalem, Z.; Shah, M.A.; Reshi, Z.; Sabit, H.; et al. A Wild Fomes fomentarius for Biomediation of One Pot Synthesis of Titanium Oxide and Silver Nanoparticles for Antibacterial and Anticancer Application. Biomolecules 2020, 10, 622.
  100. Rehman, S.; Jermy, R.; Mousa Asiri, S.; Shah, M.A.; Farooq, R.; Ravinayagam, V.; Azam Ansari, M.; Alsalem, Z.; Al Jindan, R.; Reshi, Z.; et al. Using Fomitopsis pinicola for bioinspired synthesis of titanium dioxide and silver nanoparticles, targeting biomedical applications. RSC Adv. 2020, 10, 32137–32147.
  101. Mohanta, Y.; Nayak, D.; Biswas, K.; Singdevsachan, S.; Abd_Allah, E.; Hashem, A.; Alqarawi, A.; Yadav, D.; Mohanta, T. Silver Nanoparticles Synthesized Using Wild Mushroom Show Potential Antimicrobial Activities against Food Borne Pathogens. Molecules 2018, 23, 655.
  102. Dandapat, S.; Kumar, M.; Ranjan, R.; Sinha, M.P. Ganoderma applanatum extract mediated synthesis of silver nanoparticles. Braz. J. Pharm. Sci. 2022, 58, e19173.
  103. Shivashankar, M.; Premkumari, B.; Chandan, N. Biosynthesis, partial characterization and antimicrobial activities of silver nanoparticles from Pleurotus species. Int. J. Integr. Sci. Innov. Technol. 2013, 2, 13–23.
  104. Jaloot, A.S.; Owaid, M.N.; Naeem, G.A.; Muslim, R.F. Mycosynthesizing and characterizing silver nanoparticles from the mushroom Inonotus hispidus (Hymenochaetaceae), and their antibacterial and antifungal activities. Environ. Nanotechnol. Monit. Manag. 2020, 14, 100313.
  105. Vamanu, E.; Ene, M.; Biță, B.; Ionescu, C.; Crăciun, L.; Sârbu, I. In Vitro Human Microbiota Response to Exposure to Silver Nanoparticles Biosynthesized with Mushroom Extract. Nutrients 2018, 10, 607.
  106. Javier, K.R.A.; Camacho, D.H. Dataset on the optimization by response surface methodology for the synthesis of silver nanoparticles using Laxitextum bicolor mushroom. Data Brief 2022, 45, 108631.
  107. Debnath, G.; Das, P.; Saha, A.K. Characterization, Antimicrobial and α-Amylase Inhibitory Activity of Silver Nanoparticles Synthesized by using Mushroom Extract of Lentinus tuber-regium. Proc. Natl. Acad. Sci. India Sect. B Biol. Sci. 2020, 90, 37–45.
  108. Balashanmugam, P.; Santhosh, S.; Giyaullah, H.; Balakumaran, M.D. Mycosynthesis, characterization and antibacterial activity of silver nanoparticles from Microporus xanthopus: A macro mushroom. Int. J. Innov. Res. Sci. Eng. Technol. 2007, 2, 6262–6270.
  109. Saravanan, M.; Arokiyaraj, S.; Lakshmi, T.; Pugazhendhi, A. Synthesis of silver nanoparticles from Phenerochaete chrysosporium (MTCC-787) and their antibacterial activity against human pathogenic bacteria. Microb. Pathog. 2018, 117, 68–72.
  110. Aziz, N.; Faraz, M.; Sherwani, M.A.; Fatma, T.; Prasad, R. Illuminating the Anticancerous Efficacy of a New Fungal Chassis for Silver Nanoparticle Synthesis. Front. Chem. 2019, 7, 65.
  111. Kaur, G.; Kalia, A.; Sodhi, H.S. Size controlled, time-efficient biosynthesis of silver nanoparticles from Pleurotus florida using ultra-violet, visible range, and microwave radiations. Inorg. Nano-Met. Chem. 2020, 50, 35–41.
  112. Acay, H.; Baran, M. Determination of Antioxidant and cytotoxic activities of king oyster mushroom mediated AgNPs synthesized with environmentally friendly methods. Med. Sci. 2020, 9, 760–765.
  113. Chaturvedi, V.K.; Yadav, N.; Rai, N.K.; Ellah, N.H.A.; Bohara, R.A.; Rehan, I.F.; Marraiki, N.; Batiha, G.E.-S.; Hetta, H.F.; Singh, M.P. Pleurotus sajor-caju-Mediated Synthesis of Silver and Gold Nanoparticles Active against Colon Cancer Cell Lines: A New Era of Herbonanoceutics. Molecules 2020, 25, 3091.
  114. Martínez-Flores, H.E.; Contreras-Chávez, R.; Garnica-Romo, M.G. Effect of Extraction Processes on Bioactive Compounds from Pleurotus ostreatus and Pleurotus djamor: Their Applications in the Synthesis of Silver Nanoparticles. J. Inorg. Organomet. Polym. Mater. 2021, 31, 1406–1418.
  115. Chan, Y.S.; Don, M.M. Biosynthesis and structural characterization of Ag nanoparticles from white rot fungi. Mater. Sci. Eng. C 2013, 33, 282–288.
  116. Cunha, F.A.; Cunha, M.D.C.; da Frota, S.M.; Mallmann, E.J.J.; Freire, T.M.; Costa, L.S.; Paula, A.J.; Menezes, E.A.; Fechine, P.B.A. Biogenic synthesis of multifunctional silver nanoparticles from Rhodotorula glutinis and Rhodotorula mucilaginosa: Antifungal, catalytic and cytotoxicity activities. World J. Microbiol. Biotechnol. 2018, 34, 127.
  117. Arun, G.; Eyini, M.; Gunasekaran, P. Green synthesis of silver nanoparticles using the mushroom fungus Schizophyllum commune and its biomedical applications. Biotechnol. Bioprocess Eng. 2014, 19, 1083–1090.
  118. Kobashigawa, J.M.; Robles, C.A.; Martínez Ricci, M.L.; Carmarán, C.C. Influence of strong bases on the synthesis of silver nanoparticles (AgNPs) using the ligninolytic fungi Trametes trogii. Saudi J. Biol. Sci. 2019, 26, 1331–1337.
  119. Anthony, K.J.P.; Murugan, M.; Jeyaraj, M.; Rathinam, N.K.; Sangiliyandi, G. Synthesis of silver nanoparticles using pine mushroom extract: A potential antimicrobial agent against E. coli and B. subtilis. J. Ind. Eng. Chem. 2014, 20, 2325–2331.
  120. Philip, D. Biosynthesis of Au, Ag and Au–Ag nanoparticles using edible mushroom extract. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2009, 73, 374–381.
  121. Zhao, X.; Zhou, L.; Riaz Rajoka, M.S.; Yan, L.; Jiang, C.; Shao, D.; Zhu, J.; Shi, J.; Huang, Q.; Yang, H.; et al. Fungal silver nanoparticles: Synthesis, application and challenges. Crit. Rev. Biotechnol. 2018, 38, 817–835.
  122. Guilger-Casagrande, M.; Lima, R. de Synthesis of Silver Nanoparticles Mediated by Fungi: A Review. Front. Bioeng. Biotechnol. 2019, 7, 287.
  123. Al-Ansari, M.M.; Dhasarathan, P.; Ranjitsingh, A.J.A.; Al-Humaid, L.A. Ganoderma lucidum inspired silver nanoparticles and its biomedical applications with special reference to drug resistant Escherichia coli isolates from CAUTI. Saudi J. Biol. Sci. 2020, 27, 2993–3002.
  124. Aygün, A.; Özdemir, S.; Gülcan, M.; Cellat, K.; Şen, F. Synthesis and characterization of Reishi mushroom-mediated green synthesis of silver nanoparticles for the biochemical applications. J. Pharm. Biomed. Anal. 2020, 178, 112970.
  125. Dat, T.D.; Viet, N.D.; Dat, N.M.; My, P.L.T.; Thinh, D.B.; Thy, L.T.M.; Huong, L.M.; Khang, P.T.; Hai, N.D.; Nam, H.M.; et al. Characterization and bioactivities of silver nanoparticles green synthesized from Vietnamese Ganoderma lucidum. Surf. Interfaces 2021, 27, 101453.
  126. Iruoma, C.A.; Reginald, E.E.; Motunrayo, O.; Ezinwa, I.U. Green Synthesis of Silver Nanoparticles Using Pleurotus ostreatus. J. Appl. Life Sci. Int. 2021, 1–10.
  127. Bhardwaj, A.K.; Naraian, R. Green synthesis and characterization of silver NPs using oyster mushroom extract for antibacterial efficacy. J. Chem. Environ. Sci. Its Appl. 2020, 7, 13–18.
  128. Vetchinkina, E.; Loshchinina, E.; Kupryashina, M.; Burov, A.; Pylaev, T.; Nikitina, V. Green synthesis of nanoparticles with extracellular and intracellular extracts of basidiomycetes. PeerJ 2018, 6, e5237.
  129. Ahmed, S.; Annu; Ikram, S.; Yudha, S.S. Biosynthesis of gold nanoparticles: A green approach. J. Photochem. Photobiol. B Biol. 2016, 161, 141–153.
  130. Elahi, N.; Kamali, M.; Baghersad, M.H. Recent biomedical applications of gold nanoparticles: A review. Talanta 2018, 184, 537–556.
  131. Kalimuthu, K.; Cha, B.S.; Kim, S.; Park, K.S. Eco-friendly synthesis and biomedical applications of gold nanoparticles: A review. Microchem. J. 2020, 152, 104296.
  132. Eskandari-Nojedehi, M.; Jafarizadeh-Malmiri, H.; Rahbar-Shahrouzi, J. Hydrothermal green synthesis of gold nanoparticles using mushroom (Agaricus bisporus) extract: Physico-chemical characteristics and antifungal activity studies. Green Process. Synth. 2018, 7, 38–47.
  133. Dheyab, M.A.; Owaid, M.N.; Rabeea, M.A.; Aziz, A.A.; Jameel, M.S. Mycosynthesis of gold nanoparticles by the Portabello mushroom extract, Agaricaceae, and their efficacy for decolorization of Azo dye. Environ. Nanotechnol. Monit. Manag. 2020, 14, 100312.
  134. Krishnamoorthi, R.; Bharathakumar, S.; Malaikozhundan, B.; Mahalingam, P.U. Mycofabrication of gold nanoparticles: Optimization, characterization, stabilization and evaluation of its antimicrobial potential on selected human pathogens. Biocatal. Agric. Biotechnol. 2021, 35, 102107.
  135. Hemashekhar, B.; Chandrappa, C.P.; Govindappa, M.; Chandrashekar, N. Endophytic fungus Alternaria spp isolated from Rauvolfia tetraphylla root arbitrate synthesis of gold nanoparticles and evaluation of their antibacterial, antioxidant and antimitotic activities. Adv. Nat. Sci. Nanosci. Nanotechnol. 2019, 10, 035010.
  136. Jha, P.; Saraf, A.; Sohal, J.K. Antimicrobial Activity of Biologically Synthesized Gold Nanoparticles from Wild Mushroom Cantharellus Species. J. Sci. Res. 2021, 65, 78–83.
  137. Naeem, G.A.; Jaloot, A.S.; Owaid, M.N.; Muslim, R.F. Green Synthesis of Gold Nanoparticles from Coprinus comatus, Agaricaceae, and the Effect of Ultraviolet Irradiation on Their Characteristics. Walailak J. Sci. Technol. 2021, 18, 9396.
  138. Rabeea, M.A.; Owaid, M.N.; Aziz, A.A.; Jameel, M.S.; Dheyab, M.A. Mycosynthesis of gold nanoparticles using the extract of Flammulina velutipes, Physalacriaceae, and their efficacy for decolorization of methylene blue. J. Environ. Chem. Eng. 2020, 8, 103841.
  139. Naimi-Shamel, N.; Pourali, P.; Dolatabadi, S. Green synthesis of gold nanoparticles using Fusarium oxysporum and antibacterial activity of its tetracycline conjugant. J. Mycol. Médicale 2019, 29, 7–13.
  140. Clarance, P.; Luvankar, B.; Sales, J.; Khusro, A.; Agastian, P.; Tack, J.-C.; Al Khulaifi, M.M.; AL-Shwaiman, H.A.; Elgorban, A.M.; Syed, A.; et al. Green synthesis and characterization of gold nanoparticles using endophytic fungi Fusarium solani and its in-vitro anticancer and biomedical applications. Saudi J. Biol. Sci. 2020, 27, 706–712.
  141. Abdul-Hadi, S.Y.; Owaid, M.N.; Rabeea, M.A.; Abdul Aziz, A.; Jameel, M.S. Rapid mycosynthesis and characterization of phenols-capped crystal gold nanoparticles from Ganoderma applanatum, Ganodermataceae. Biocatal. Agric. Biotechnol. 2020, 27, 101683.
  142. Elumalai, D.; Suman, T.Y.; Hemavathi, M.; Swetha, C.; Kavitha, R.; Arulvasu, C.; Kaleena, P.K. Biofabrication of gold nanoparticles using Ganoderma lucidum and their cytotoxicity against human colon cancer cell line (HT-29). Bull. Mater. Sci. 2021, 44, 132.
  143. Shukurov, I.; Mohamed, M.S.; Mizuki, T.; Palaninathan, V.; Ukai, T.; Hanajiri, T.; Maekawa, T. Biological Synthesis of Bioactive Gold Nanoparticles from Inonotus obliquus for Dual Chemo-Photothermal Effects against Human Brain Cancer Cells. Int. J. Mol. Sci. 2022, 23, 2292.
  144. Farzana Fathima, M.R.; Usha Raja Nanthini, A.; Al-Khattaf, F.S.; Hatamleh, A.A.; Kabir, S.B. Mycosynthesis of Noble Metal Nanoparticle Using Laetiporus versisporus Mushroom and Analysis of Antioxidant Activity. J. Nanomater. 2022, 2022, 8086803.
  145. Owaid, M.N.; Rabeea, M.A.; Abdul Aziz, A.; Jameel, M.S.; Dheyab, M.A. Mushroom-assisted synthesis of triangle gold nanoparticles using the aqueous extract of fresh Lentinula edodes (shiitake), Omphalotaceae. Environ. Nanotechnol. Monit. Manag. 2019, 12, 100270.
  146. Vetchinkina, E.P.; Loshchinina, E.A.; Vodolazov, I.R.; Kursky, V.F.; Dykman, L.A.; Nikitina, V.E. Biosynthesis of nanoparticles of metals and metalloids by basidiomycetes. Preparation of gold nanoparticles by using purified fungal phenol oxidases. Appl. Microbiol. Biotechnol. 2017, 101, 1047–1062.
  147. Acay, H. Utilization of Morchella esculenta -mediated green synthesis golden nanoparticles in biomedicine applications. Prep. Biochem. Biotechnol. 2021, 51, 127–136.
  148. Soltani Nejad, M.; Samandari Najafabadi, N.; Aghighi, S.; Pakina, E.; Zargar, M. Evaluation of Phoma sp. Biomass as an Endophytic Fungus for Synthesis of Extracellular Gold Nanoparticles with Antibacterial and Antifungal Properties. Molecules 2022, 27, 1181.
  149. Abdel-Kareem, M.M.; Zohri, A.A. Extracellular mycosynthesis of gold nanoparticles using Trichoderma hamatum: Optimization, characterization and antimicrobial activity. Lett. Appl. Microbiol. 2018, 67, 465–475.
  150. do Nascimento, J.M.; Cruz, N.D.; de Oliveira, G.R.; Sá, W.S.; de Oliveira, J.D.; Ribeiro, P.R.S.; Leite, S.G.F. Evaluation of the kinetics of gold biosorption processes and consequent biogenic synthesis of AuNPs mediated by the fungus Trichoderma harzianum. Environ. Technol. Innov. 2021, 21, 101238.
  151. Basu, A.; Ray, S.; Chowdhury, S.; Sarkar, A.; Mandal, D.P.; Bhattacharjee, S.; Kundu, S. Evaluating the antimicrobial, apoptotic, and cancer cell gene delivery properties of protein-capped gold nanoparticles synthesized from the edible mycorrhizal fungus Tricholoma crassum. Nanoscale Res. Lett. 2018, 13, 154.
  152. Molnár, Z.; Bódai, V.; Szakacs, G.; Erdélyi, B.; Fogarassy, Z.; Sáfrán, G.; Varga, T.; Kónya, Z.; Tóth-Szeles, E.; Szűcs, R.; et al. Green synthesis of gold nanoparticles by thermophilic filamentous fungi. Sci. Rep. 2018, 8, 3943.
  153. Loshchinina, E.A.; Vetchinkina, E.P.; Kupryashina, M.A.; Kursky, V.F.; Nikitina, V.E. Nanoparticles synthesis by Agaricus soil basidiomycetes. J. Biosci. Bioeng. 2018, 126, 44–52.
  154. Jeyaraj, M.; Gurunathan, S.; Qasim, M.; Kang, M.-H.; Kim, J.-H. A Comprehensive Review on the Synthesis, Characterization, and Biomedical Application of Platinum Nanoparticles. Nanomaterials 2019, 9, 1719.
  155. Fahmy, S.A.; Preis, E.; Bakowsky, U.; Azzazy, H.M.E.-S. Platinum Nanoparticles: Green Synthesis and Biomedical Applications. Molecules 2020, 25, 4981.
  156. Muñiz-Diaz, R.; Gutiérrez de la Rosa, S.Y.; Gutiérrez Coronado, Ó.; Patakfalvi, R. Biogenic synthesis of platinum nanoparticles. Chem. Pap. 2022, 76, 2573–2594.
  157. Sarkar, J.; Acharya, K. Alternaria alternata culture filtrate mediated bioreduction of chloroplatinate to platinum nanoparticles. Inorg. Nano-Met. Chem. 2017, 47, 365–369.
  158. Riddin, T.L.; Gericke, M.; Whiteley, C.G. Analysis of the inter- and extracellular formation of platinum nanoparticles by Fusarium oxysporum f. sp. lycopersici using response surface methodology. Nanotechnology 2006, 17, 3482–3489.
  159. Govender, Y.; Riddin, T.; Gericke, M.; Whiteley, C.G. Bioreduction of platinum salts into nanoparticles: A mechanistic perspective. Biotechnol. Lett. 2009, 31, 95–100.
  160. Govender, Y.; Riddin, T.L.; Gericke, M.; Whiteley, C.G. On the enzymatic formation of platinum nanoparticles. J. Nanoparticle Res. 2010, 12, 261–271.
  161. Syed, A.; Ahmad, A. Extracellular biosynthesis of platinum nanoparticles using the fungus Fusarium oxysporum. Colloids Surf. B Biointerfaces 2012, 97, 27–31.
  162. Gupta, K.; Chundawat, T.S. Bio-inspired synthesis of platinum nanoparticles from fungus Fusarium oxysporum: Its characteristics, potential antimicrobial, antioxidant and photocatalytic activities. Mater. Res. Express 2019, 6, 1050d6.
  163. Castro-Longoria, E. Production of Platinum Nanoparticles and Nanoaggregates Using Neurospora crassa. J. Microbiol. Biotechnol. 2012, 22, 1000–1004.
  164. Subramaniyan, S.A.; Sheet, S.; Vinothkannan, M.; Yoo, D.J.; Lee, Y.S.; Belal, S.A.; Shim, K.S. One-Pot Facile Synthesis of Pt Nanoparticles Using Cultural Filtrate of Microgravity Simulated Grown P. chrysogenum and Their Activity on Bacteria and Cancer Cells. J. Nanosci. Nanotechnol. 2018, 18, 3110–3125.
  165. Borse, V.; Kaler, A.; Banerjee, U.C. Microbial Synthesis of Platinum Nanoparticles and Evaluation of Their Anticancer Activity. Int. J. Emerg. Trends Electr. Electron. 2015, 11, 26–31.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
ScholarVision Creations
Feedback